First Wave of COVID-19 in French Patients with Cystic Fibrosis - Centre de recherche Saint-Antoine - UMR S938 Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Medicine Année : 2020

First Wave of COVID-19 in French Patients with Cystic Fibrosis

Sandra de Miranda
  • Fonction : Auteur
  • PersonId : 1085823
Lydie Lemonnier
  • Fonction : Auteur
  • PersonId : 1085824
Isabelle Durieu
  • Fonction : Auteur
  • PersonId : 848032
Véronique Houdouin
  • Fonction : Auteur
  • PersonId : 1029283
Anne Prevotat
  • Fonction : Auteur
  • PersonId : 1085825
Sophie Ramel
  • Fonction : Auteur
  • PersonId : 1085826
Laurence Weiss
  • Fonction : Auteur
  • PersonId : 1085828

Résumé

Viral infections are known to lead to serious respiratory complications in cystic fibrosis (CF) patients. Hypothesizing that CF patients were a population at high risk for severe respiratory complications from SARS-CoV-2 infection, we conducted a national study to describe the clinical expression of COVID-19 in French CF patients. This prospective observational study involves all 47 French CF centers caring for approximately 7500 CF patients. Between March 1st and June 30th 2020, 31 patients were diagnosed with COVID-19: 19 had positive SARS-CoV-2 RT-PCR in nasopharyngeal swabs; 1 had negative RT-PCR but typical COVID-19 signs on a CT scan; and 11 had positive SARS-CoV-2 serology. Fifteen were males, median (range) age was 31 (9–60) years, and 12 patients were living with a lung transplant. The majority of the patients had CF-related diabetes (n = 19, 61.3%), and a mild lung disease (n = 19, 65%, with percent-predicted forced expiratory volume in 1 s (ppFEV1) > 70). Three (10%) patients remained asymptomatic. For the 28 (90%) patients who displayed symptoms, most common symptoms at admission were fever (n = 22, 78.6%), fatigue (n = 14, 50%), and increased cough (n = 14, 50%). Nineteen were hospitalized (including 11 out of the 12 post-lung transplant patients), seven required oxygen therapy, and four (3 post-lung transplant patients) were admitted to an Intensive Care Unit (ICU). Ten developed complications (including acute respiratory distress syndrome in two post-lung transplant patients), but all recovered and were discharged home without noticeable short-term sequelae. Overall, French CF patients were rarely diagnosed with COVID-19. Further research should establish whether they were not infected or remained asymptomatic upon infection. In diagnosed cases, the short-term evolution was favorable with rare acute respiratory distress syndrome and no death. Post-lung transplant patients had more severe outcomes and should be monitored more closely. View Full-Text
Fichier principal
Vignette du fichier
jcm-09-03624-v2.pdf (1.25 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03062381 , version 1 (14-12-2020)

Identifiants

Citer

Harriet Corvol, Sandra de Miranda, Lydie Lemonnier, Astrid Kemgang, Martine Reynaud Gaubert, et al.. First Wave of COVID-19 in French Patients with Cystic Fibrosis. Journal of Clinical Medicine, 2020, 9 (11), pp.3624. ⟨10.3390/jcm9113624⟩. ⟨hal-03062381⟩
124 Consultations
97 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More